News & Updates

The Malaysian Renal Nerve Denervation Working Group (MyRDN), a partnership between the Malaysia Society of Hypertension (MSH) and the National Heart Association of Malaysia (NHAM), recently previewed their consensus document on renal denervation. The paper outlines recommendations and guidelines for healthcare professionals regarding the use of this procedure in the treatment of people with hypertension.

The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.

A peak systolic blood pressure (SBP) at clinical exercise testing that is slightly lower than the predicted value appears predictive of future cardiovascular disease (CVD) and mortality, suggests a study. Higher peak SBP, however, is not associated with such risks.